GSK

GSK On Track With Consumer Split Amid Buyout Report

GlaxoSmithKline is 'firmly on track' to spin off its consumer health business next year, the British drugmaker has said, after Bloomberg News reported the...

GSK To Set Up Two New Headquarters

GlaxoSmithKline on Monday laid out plans for a new, £120 million (€141.3 million) headquarters for its soon-to-be-independent consumer healthcar...

Activist Investor Bluebell Takes Stake In GSK

Activist investor Bluebell Capital Partners has taken a stake worth about €10 million in British pharmaceuticals group GlaxoSmithKline in efforts to s...

GSK Names Brian McNamara As CEO Of New Spin-Off

British drugmaker GSK said on Thursday its consumer healthcare head, Brian McNamara, will take over as the chief executive officer of the unit on...

GSK Rejects Elliott's Demands For Board, Consumer Business

GSK's board on Friday rejected Elliott's demands that the British company change its board and sell its consumer healthcare arm after separating it from it...

GSK Unveils Plan For Consumer Healthcare Unit

Britain's GSK has unveiled a detailed plan to spin off its consumer healthcare venture with Pfizer into a separate company by the middle of next...

GSK To Boost Spending Power Of Pharma Business Post Break-up

GlaxoSmithKline will lay out plans to boost the spending power of its research-focused pharmaceuticals business at an investor day on Wednesday, as analyst...